In neurodegenerative diseases like Alzheimer’s and Parkinson’s, this priming may drive chronic neuroinflammation, as primed microglia respond excessively to Aβ or α-synuclein accumulation, exacerbating neuronal damage [49]. This evidence concerns the gene SNCA and Parkinsonism.